Nigeria approves 35 new linear accelerators to boost cancer treatment

The Federal Government of Nigeria has approved the purchase of 35 additional linear accelerators, a move aimed at significantly enhancing cancer treatment accessibility nationwide. These machines are slated for procurement between 2027 and 2029, with the goal of expanding the country's capacity to offer radiotherapy services to cancer patients.

Minister of State for Health and Social Welfare, Dr. Iziaq Salako, announced the approval in Abuja. He stated that this initiative is a key component of the government's National Cancer Control Plan for 2026–2030, which prioritizes strengthening cancer care. Salako also noted that construction is underway for six cancer centers, with three already completed and the remaining three in progress.

“

Prevention is better and cheaper than cure.

Beyond treatment, the government is placing a strong emphasis on cancer prevention and early detection. "Prevention is better and cheaper than cure," Salako remarked, highlighting efforts to expand routine immunization, broaden screening programs, and improve early detection methods. The inclusion of the human papillomavirus (HPV) vaccine in routine immunization is one strategy to prevent cervical cancer, alongside expanded screening services at primary and secondary healthcare levels.

In a related development, the Blood Cancer Consortium was inaugurated. This platform is designed to foster collaboration among health professionals and stakeholders to improve the management of blood cancers in Nigeria. The Permanent Secretary of the ministry, Daju Kachollom, stressed the importance of stakeholder collaboration for better cancer outcomes. Professor Folakemi Odedina, Chairman of the National Cancer Control Plan Technical Working Group, added that the initiative unites Nigerian cancer experts, healthcare providers, researchers, patients, and international partners. Efforts are also focused on strengthening cancer research and developing a more effective national system for oncology clinical trials, with partnerships aimed at enhancing Nigeria's capacity in these areas.

“

We are doing everything possible to expand routine immunisation, broaden screening and improve early detection.